反应详情

To a solution of 5-amino-4-(2-tert-butoxycarbonylaminoethyl)-1-(2-triphenylmethyloxyethyl)-1H-pyrazole (1.24 g) in dichloromethane (5 ml) were added trimethylsilyl iodide (0.688 ml) and diisopropylethylamine (0.842 ml) under ice-cooling, and the mixture was stirred under ice-cooling for 2 hours. To the reaction mixture was added a mixture of benzhydryl 7β-[(Z)-2-(5-tert-butoxycarbonylamino-1,2,4-thiadiazol-3-yl)-2-(1-tert-butoxycarbonyl-1-methylethoxyimino)acetamido]-3-chloromethyl-3-cephem-4-carboxylate (1 g) and sodium iodide (182 mg) in N,N-dimethylformamide (2 ml) which had been stirred under ice-cooling for 30 minutes and at room temperature for 18 hours. The reaction mixture was added to a mixture of ethyl acetate and water. The organic layer was separated and dried over magnesium sulfate. The magnesium sulfate was filtered off, and the filtrate was evaporated to about 20 ml under reduced pressure. The concentrate was poured into diisopropyl ether (150 ml), and the resulting precipitate was collected by filtration and dried in vacuo. To a solution of the resulting solid in methylene chloride (3 ml) were added anisole (1 ml) and trifluoroacetic acid (2 ml). The resulting solution was stirred at room temperature for 3 hours and poured into diisopropyl ether. The resulting precipitate was collected by filtration and dried in vacuo. The obtained powder was dissolved in a phosphate buffer (pH 7) and adjusted to about pH 6 with saturated aqueous sodium hydrogencarbonate solution. The solution containing the objective compound was purified by preparative HPLC utilizing ODS column. The eluate containing a desired product was concentrated in vacuo. The concentrate was adjusted to about pH 2 with concentrated hydrochloric acid and chromatographed on Diaion® HP-20 (Mitsubishi Chemical Corporation) eluting with 20% aqueous 2-propanol. The eluate was evaporated in vacuo and lyophilized to give 7β-[(Z)-2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(1-carboxy-1-methylethoxyimino)acetamido]-3-[3-amino-4-(2-aminoethyl)-2-(2-hydroxyethyl)-1-pyrazolio]methyl-3-cephem-4-carboxylate (66.4 mg) as an amorphous solid.

1. temperaturecooling
2. temperaturecooling for 2 hours
3. additionTo the reaction mixture was added
4. stirringhad been stirred under ice-
5. customThe organic layer was separated
6. dry with materialdried over magnesium sulfate
7. filtrationThe magnesium sulfate was filtered off
8. customthe filtrate was evaporated to about 20 ml under reduced pressure
9. additionThe concentrate was poured into diisopropyl ether (150 ml)
10. filtrationthe resulting precipitate was collected by filtration
11. customdried in vacuo
12. additionTo a solution of the resulting solid in methylene chloride (3 ml) were added anisole (1 ml) and trifluoroacetic acid (2 ml)
13. stirringThe resulting solution was stirred at room temperature for 3 hours
14. additionpoured into diisopropyl ether
15. filtrationThe resulting precipitate was collected by filtration
16. customdried in vacuo
17. dissolutionThe obtained powder was dissolved in a phosphate buffer (pH 7)
18. additionThe solution containing the objective compound
19. customwas purified by preparative HPLC utilizing ODS column
20. additionThe eluate containing a desired product
21. concentrationwas concentrated in vacuo
22. customchromatographed on Diaion®
23. wash(Mitsubishi Chemical Corporation) eluting with 20% aqueous 2-propanol
24. customThe eluate was evaporated in vacuo